![VaxInnate Logo](/news-release/logo/313305/0/313305.jpg?lastModified=12%2F09%2F2016%2023%3A16%3A03&size=2)
VaxInnate Updates Plans to Advance Lead Vaccine Candidate, VAX2012Q in Elderly
08 oct. 2014 09h00 HE
|
VaxInnate Corporation
Cranbury, NJ, Oct. 8, 2014 (GLOBE NEWSWIRE) -- VaxInnate Corporation, a biotechnology firm pioneering a
breakthrough vaccine technology platform, provided an update on
clinical development plans for...